Novodiag® RESP-4 Assay

    CE marked. Not for sale in the US.

    Novodiag® RESP-4 Assay

    Fully-automated on-demand testing that enables differentiated detection of SARS-CoV-2, Flu A, Flu B and RSV.

      Assay Highlights

      The Novodiag RESP-4 assay, performed with the Novodiag System, is a cartridge-based molecular test for the detection and differentiation of SARS-CoV-2, Flu A, Flu B and RSV in one single assay. The test uses nasopharyngeal swab samples from patients.

      CE marked. Not for sale in the US.

      Smart Simplicity in On-demand Testing

      Cartridge-based, on-demand testing, that delivers clinical confidence in approximately an hour.

      Placeholder image

      Features & Benefits

      The Novodiag® Solution allows a simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing.

        • Accurate diagnosis during respiratory viral season.
        • Guiding appropriate treatment of patients.
        • Reliable results.
        • Prevention of false negative results due to inadequate sampling.
        • Good reproducibility, precision and productivity.
        • Ensures users safety, protects from possible contamination.
        • Fast diagnosis and infection control implementation.
        • Time and cost effectiveness.
        • Improved patient outcome
        • Improved workflow and time to results.
        • Increased lab revenue.
        • Time and labour saving.
        • No need for highly trained personnel enabling decentralised testing.

        Need Support?

        All Other Requests

        Documents

        The Novodiag RESP-4 assay enables fast on-demand diagnosis of SARS-CoV-2, Flu A, Flu B and RSV.

        Instructions for Use

        Please go to our e-labeling portal to download your document.